(-0.46%) 5 048.42 points
(-0.98%) 38 086 points
(-0.64%) 15 612 points
(0.30%) $83.82
(-2.38%) $1.599
(0.23%) $2 348.00
(0.50%) $27.49
(0.98%) $929.50
(0.08%) $0.932
(0.11%) $10.96
(0.06%) $0.800
(0.02%) $92.18
Live Chart Being Loaded With Signals
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products...
Stats | |
---|---|
Today's Volume | 157 600 |
Average Volume | 618 386 |
Market Cap | 512.23B |
EPS | ¥0 ( 2024-02-04 ) |
Next earnings date | ( ¥41.18 ) 2024-05-13 |
Last Dividend | ¥23.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 13.98 |
ATR14 | ¥1.188 (0.05%) |
Volume Correlation
MediPal Holdings Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
MediPal Holdings Correlation - Currency/Commodity
MediPal Holdings Financials
Annual | 2022 |
Revenue: | ¥3 360.01B |
Gross Profit: | ¥224.31B (6.68 %) |
EPS: | ¥184.82 |
Q3 | 2023 |
Revenue: | ¥935.93B |
Gross Profit: | ¥65.30B (6.98 %) |
EPS: | ¥52.80 |
Q2 | 2023 |
Revenue: | ¥892.25B |
Gross Profit: | ¥62.04B (6.95 %) |
EPS: | ¥28.08 |
Q1 | 2023 |
Revenue: | ¥886.74B |
Gross Profit: | ¥59.34B (6.69 %) |
EPS: | ¥52.32 |
Financial Reports:
No articles found.
MediPal Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥23.00 (N/A) |
¥0 (N/A) |
¥23.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥6.00 | 2001-03-27 |
Last Dividend | ¥23.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 46 | -- |
Total Paid Out | ¥539.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.98 | -- |
Div. Sustainability Score | 5.56 | |
Div.Growth Potential Score | 4.60 | |
Div. Directional Score | 5.08 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8137.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7487.T | Ex Dividend Junior | 2024-05-30 | Annually | 0 | 0.00% | |
6715.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
6059.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
4739.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3983.T | Ex Dividend Knight | 2023-12-28 | Annually | 0 | 0.00% | |
3193.T | Ex Dividend Junior | 2024-01-30 | Annually | 0 | 0.00% | |
2183.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
9055.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7943.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0106 | 1.500 | 9.79 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0199 | 1.200 | 9.34 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0646 | 1.500 | -0.393 | -0.590 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.198 | 0.800 | 9.01 | 7.21 | [1 - 3] |
quickRatioTTM | 0.928 | 0.800 | 9.25 | 7.40 | [0.8 - 2.5] |
cashRatioTTM | 0.194 | 1.500 | -0.0355 | -0.0533 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 2 432.80 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 259.54 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 259.54 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.0685 | 1.000 | -2.19 | -2.19 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0139 | 1.000 | -1.723 | -1.723 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 1.872 | 0.800 | 0.854 | 0.683 | [0.5 - 2] |
Total Score | 5.56 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 13.66 | 1.000 | 8.72 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0646 | 2.50 | -0.253 | -0.590 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 259.54 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.49 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 259.54 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.594 | 1.500 | 9.37 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0156 | 1.000 | -2.11 | 0 | [0.1 - 0.5] |
Total Score | 4.60 |
MediPal Holdings
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators